5.
Commonly used second-line chemotherapy regimens for NSCLC
| Regimen | Dose | Medication time | Cycle length |
| Docetaxel | 75 mg/m2 | d 1 | 21 d |
| Pemetrexed
(non-squamous) |
500 mg/m2 | d 1 | 21 d |
| Afatinib (squamous) | 40 mg | Qd | Qd |
| Osimertinib (T790M) | 80 mg | Qd | Qd |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.